Back to all studies
ðŸ§
Phase 2
Mental Health
in-person
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Sponsored by Alto Neuroscience
Compensation
$500–$2,500
Duration
3 months
Location
Nationwide
About this study
The purpose of this trial is to measure depressive symptoms following treatment with ALTO-207 compared with placebo in participants with TRD.
Who can participate
- • Adults aged 18–75
- • All genders welcome
- • Diagnosed with or experiencing treatment-resistant depression (trd)
- • Able to attend in-person clinic visits
What's included
- • Compensation up to $2,500
- • All study-related medical care at no cost
- • Lab work, screenings, and physician consultations
- • Study medication or treatment provided
IRB-approved study. Free to apply. Your information is kept confidential.
Ready to Find a Paid Study?
Join over 100,000 people who have been matched with clinical studies. It's free, fast, and could change your life.